REQUEST A DEMO
Total
USD $0.00
Search more companies

Genmont Biotech Incorporation (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Genmont Biotech Incorporation Profile Updated: May 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

In December 2000 King Yue was established. In June 2001 it leased 0.8 hectares of land in " No.2455 Shanhua Section Shanhua Township".In August 2001 it began to set up the new plant. In January 2002,it carried out the high-density culture bacteria and established the upstream and downstream engineering systems of the related procedures. In March 2002 it went public. In May 2002 it began test. In July 2002 it obtained factory registration certificate and business license. In August 2002, it signed technology licensing and raw material sale contracts with Shengde Pharmaceutical Company. In September 2002,it put into mass production. In October 2002, it signed sales contracts with Uni Enterprise and Guanghui Biotechnology.In January 2003; it signed technology licensing and raw material sale contracts with China Pharmaceutical.

Headquarters
No.8, Nan-Ke 7Th Rd Shanhua Dist, Tainan Science-Based Industrual Park
Tainan City; Tainan City;

Contact Details: Purchase the Genmont Biotech Incorporation report to view the information.

Website: http://www.genmont.com.tw

Basic Information
Total Employees:
Purchase the Genmont Biotech Incorporation report to view the information.
Outstanding Shares:
Purchase the Genmont Biotech Incorporation report to view the information.
Financial Auditors:
Purchase the Genmont Biotech Incorporation report to view the information.
Incorporation Date:
December 06, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
8.98%
Purchase this report to view the information.
2.74%
Purchase this report to view the information.
1.83%
Purchase this report to view the information.
0.01%
Purchase this report to view the information.
Subsidiaries
景岳生物科技(中國)有限公司 (China)
85%
Company Performance
Financial values in the chart are available after Genmont Biotech Incorporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
20.71%
Total operating revenue
20.71%
Operating profit (EBIT)
51.4%
EBITDA
75.78%
Net Profit (Loss) for the Period
76.66%
Total assets
2.12%
Total equity
1.19%
Operating Profit Margin (ROS)
2.91%
Net Profit Margin
5.16%
Return on Equity (ROE)
1.38%
Debt to Equity Ratio
3.84%
Quick Ratio
0.57%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?